Projects per year
Personal profile
Research expertise
Marie joined ITM in 1984 to work on sexually transmitted infections and HIV, first in Nairobi, Kenya and in Kinshasa, DRC (Project SIDA) and later in Côte d’Ivoire ( Project Retro-CI ).
She did numerous short term missions to Africa and Asia, focusing on better understanding of the HIV epidemic as well as designing and evaluating interventions to address the epidemic.
Marie Laga and her team contributed significantly to HIV prevention science in the area’s of sexual transmission and its co-factors, prevention programs for vulnerable groups such as female sex workers, youth and men who have sex with men, evaluation of female controlled methods and linkages of sexual and reproductive health. In recent years, Marie Laga has become a leading expert in HIV prevention, advocating for intensifying HIV prevention worldwide.
She provides policy support and technical assistance in the areas of strengthening HIV prevention for numerous international and local organisations.
Research themes
- Development and evaluation of interventions to prevent the transmission of HIV and other sexually transmitted infections between commercial sex workers and their clients.
- Development and evaluation of interventions to reduce unsafe sexual behaviour among young people.
- Clinical trials to test the safety and effectiveness of vaginal microbicides (these are products that women can insert into the vagina and that are designed to block the transmission of HIV during sexual intercourse).
- Operational research on improving links between health services for HIV and services for other reproductive health problems, such as antenatal care.
- Research on the impact of HIV control programmes on general health services in developing countries.
Teaching expertise
- Prevention and Control of Tropical Diseases: Prevention and Control of
HIV/AIDS - Integration of Sexual and Reproductive Health Services
- Policy Issues in Disease Control and Reproductive Health
- HIV Control Strategies
- Care versus Prevention
Education/Academic qualification
Geaggregeerde voor het Hoger Onderwijs, PhD, University of Antwerp
1990
Epidemiology, Master of Science, London School of Hygiene and Tropical Medicine
1986 → 1987
European Course on Tropical Epidemiology, University of Antwerp
Sep-1985
Tropical Medicine, Diploma, Institute of Tropical Medicine Antwerp
1982 → 1983
Medicine, Doctor, Katholieke Universiteit Leuven
1975 → 1982
External positions
Technical panel member for programs in India (AVAHAN) and Botswana (ACHAP), Bill & Melinda Gates Foundation
Membership, Global HIV Prevention Working Group
Member of Board, Plan Belgium
Member of Board, SENSOA, Coordination of HIV & reproductive health in Flanders
Membership, UNAIDS Prevention Reference Group
Membership, UNAIDS, Think Tank on Prevention Evaluation
Membership, UNFPA Technical Panel
Membership, WHO Strategic and Technical Advisory Committee for HIV & AIDS
Fingerprint
- 1 Similar Profiles
Network
-
Queer people in straight systems: The impact of sexual orientation laws on the health of sexual minorities
Siegel, M., Laga, M., Nöstlinger, C. & Pietschnig, J.
17/04/20 → …
Project: PhD-project
-
PreP_OPTIMIZE: Optimise PrEP to Maximise Impact
Laga, M., Vuylsteke, B., Reyniers, T., Loos, J., Nöstlinger, C. & Van Aerde, K.
Fonds voor Wetenschappelijk Onderzoek
1/01/19 → 31/12/22
Project: Research Project
-
Understanding why and how adolescent friendly conditions of health services affect the health outcomes of Nigerian adolescents living with HIV
Badejo, O. A., Laga, M., Nöstlinger, C., Van Belle, S., Wouters, E. & Jolayemi, T.
1/01/19 → …
Project: PhD-project
-
Research output
-
Factors influencing SARS-CoV-2 infection rate in Belgian nursing home residents during the first wave of COVID-19 pandemic
Peckeu, L., van Kleef, E., Smekens, T., Latour, K., Dequeker, S., Int Panis, L. & Laga, M., 22-Feb-2022, In : Epidemiology and Infection. 150, e72Research output: Contribution to journal › A1: Web of Science-article
-
How do family physicians perceive their role in providing pre-exposure prophylaxis for HIV prevention? An online qualitative study in Flanders, Belgium
Vanhamel, J., Reyniers, T., Wouters, E., van Olmen, J., Vanbaelen, T., Nöstlinger, C., Mieghem, H. V., Landeghem, E. V., Rotsaert, A., Laga, M. & Vuylsteke, B., 2022, In : Frontiers in Medicine. 9, 11 p., 828695.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile -
Why do HIV pre-exposure prophylaxis users discontinue pre-exposure prophylaxis care? A mixed methods survey in a pre-exposure prophylaxis clinic in Belgium
Vanbaelen, T., Rotsaert, A., Jacobs, B. K. M., Florence, E., Kenyon, C., Vuylsteke, B., Laga, M. & Reyniers, T., 2022, In : AIDS Patient Care and STDs. 36, 4, p. 159-167 9 p.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile -
Awareness of, willingness to take PrEP and its actual use among Belgian MSM at high risk of HIV infection: secondary analysis of the Belgian European MSM Internet Survey
Buffel, V., Reyniers, T., Masquillier, C., Thunissen, E., Nöstlinger, C., Laga, M., Wouters, E., Vanden Berghe, W., Deblonde, J. & Vuylsteke, B., 2021, In : AIDS and Behavior. 15 p.Research output: Contribution to journal › A1: Web of Science-article
-
Can we predict incorrect PrEP use in high HIV risk situations among Men who have Sex with Men? An analysis of Be-PrEP-ared, the Belgian PrEP demonstration study
Vuylsteke, B., Reyniers, T., Nöstlinger, C., Smekens, T., Kenyon, C. & Laga, M., 2021, In : Journal of Acquired Immune Deficiency Syndromes. 88, 1, p. 36-44 9 p.Research output: Contribution to journal › A1: Web of Science-article